1 document found, page 1 of 1
Sort by
Issue Date
Antifibrotics in rheumatoid arthritis-associated interstitial lung disease – re...
Duarte, Ana Catarina; Marques Gomes, C.; Correia, M.; Mendes, B.; Mazeda, C.; Guimarães, F.; Abelha-Aleixo, J.; Guerra, M.; Pereira da Costa, R.Publisher Copyright: © 2024 Sociedade Portuguesa de Reumatologia.; Introduction: Interstitial lung disease (ILD) is the most common pulmonary manifestation of rheumatoid arthritis (RA) and is associated with an increased mortality. Clinical trials have shown that antifibrotics (nintedanib and pirfenidone) can slow the progression of connective tissue disease-associated ILD. This study aims to evaluate the effec...
Date: 2024
|
Origin: Repositório Institucional da UNL